✦ LIBER ✦

O-185 Overcoming hypothesized antagonism with intermittent dosingof erlotinib in combination with docetaxel (DOC) in non-small cell lung cancer (NSCLC): A phase I study

✍ Scribed by Davies, A.; Lara, P.; Lau, D.; Mack, P.; Gumerlock, P.; Gandara, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with carboplati

✍ Pectasides, D.; Aspropotamitis, A.; Halikia, A.; Visvikis, A.; Antoniou, F.; Kal 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 165 KB

209 Phase I study of docetaxel (D) (Taxo

✍ Manegold, Chr.; Buchholz, E.; Schwalb, M.; Achterrath, W.; Drings, P. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 155 KB

A phase I–II study of docetaxel (D) and

✍ Quantin, X; Rebattu, P; Pujol, J; Morere, J; Azarian, M.R; Khial, F; Dumortier, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

1081 Gemcitabine combined with cisplatin

✍ Steward, W.P.; Dunlop, D.J.; Cameron, C.; Talbot, D.C.; Kleisbauer, J.-P.; Thoma 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB

A phase I/II study of Docetaxel (Taxoter

✍ Aamdal, S; Lauvvang, G; Owre, K; Hatlevoll, R; Armellini, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

328 A phase III study of docetaxel (taxo

✍ Aamdal, S.; Wibe, E.; Hallén, M.N.; Berg, R.; Hatlevoll, R. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 317 KB